← Leaderboards
Eric Gaucher
Dna Twopointo, Inc.
$2,127,984
Attributed
$2,648,801
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $366.9K · FY2006–24$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,648,801 · 4
By mechanism
R01$1,485,889 · 1
T34$1,041,634 · 2
R41$121,278 · 1
Top collaborators
- Kyle J Frantz3 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularLeadBaseFda ApprovedAscorbic AcidEvolutionEvaluationDrug KineticsEnzyme ActivityEnzymesBindingBiochemicalBackClinically RelevantBlood CirculationDistalAdultCell PhysiologyCancer TherapyDietCrystallizationCellular AssayCatabolismEngineering
Grant awards (10)
MARC at Georgia State University$316,572
T34 · FY2024 · GM
MARC at Georgia State University: Workforce Diversity through Honors Undergraduates$358,132
T34 · FY2023 · GM
MARC at Georgia State University: Workforce Diversity through Honors Undergraduates$366,930
T34 · FY2022 · GM
Evaluation of Urate Metabolism in Mammals$292,302
R01 · FY2021 · AR · contact PI
Evaluation of Urate Metabolism in Mammals$302,821
R01 · FY2019 · AR · contact PI
Evaluation of Urate Metabolism in Mammals$304,247
R01 · FY2018 · AR · contact PI
Evaluation of Urate Metabolism in Mammals$210,747
R01 · FY2017 · AR · contact PI
Evolution of urate metabolism$45,025
R01 · FY2017 · AR · contact PI
Evolution of urate metabolism$330,747
R01 · FY2016 · AR · contact PI
Evolutionary Approaches for synthetic Library Design$121,278
R41 · FY2006 · GM · contact PI